Well Lead Medical Co., Ltd. (SHA:603309)

China flag China · Delayed Price · Currency is CNY
15.91
+0.71 (4.67%)
Mar 10, 2026, 1:45 PM CST
35.17%
Market Cap 4.44B
Revenue (ttm) 1.64B
Net Income (ttm) 244.31M
Shares Out 291.87M
EPS (ttm) 0.83
PE Ratio 18.31
Forward PE 14.69
Dividend 0.40 (2.63%)
Ex-Dividend Date Jan 8, 2026
Volume 6,844,685
Average Volume 5,163,304
Open 15.35
Previous Close 15.20
Day's Range 15.18 - 16.10
52-Week Range 9.86 - 16.02
Beta -0.13
RSI 58.66
Earnings Date Apr 23, 2026

About Well Lead Medical

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, urethral and ureteral dilation, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation acc... [Read more]

Sector Healthcare
Founded 1998
Employees 2,622
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603309
Full Company Profile

Financial Performance

In 2024, Well Lead Medical's revenue was 1.51 billion, an increase of 8.76% compared to the previous year's 1.39 billion. Earnings were 219.39 million, an increase of 13.98%.

Financial Statements

News

There is no news available yet.